menu search

Roche splashes us$7.1 billion on new irritable bowel drug

Roche has agreed to pay US$7.1 billion for an early-stage inflammatory bowel disease treatment developed by US rivals Roivant and Pfizer. For its mon...

October 23, 2023, 4:44 am

Nzd/usd mar 2025

2-Year U.S. Treasury Note Continuous Contract $101.109 0.004 0.00% 5-Year U.S. Treasury Note Continuous Contract $103.922 0.000 0.00% 10-Year U.S. Tre...

October 22, 2023, 10:44 pm

Beam: opportunity based on scd data readout in 2024

Beam Therapeutics is progressing well with its phase 1/2 BEACON study using BEAM-101 for severe sickle ...

October 22, 2023, 6:39 am

Beam to reprioritize portfolio, slash jobs, shares tank

BEAM announces a restructuring and portfolio reprioritization plan to focus on genome-editing candidate, BEAM-101. The company is set to reduce its wo...

October 20, 2023, 12:47 pm

Excision biotherapeutics announces presentation of interim clinical data for ebt-101 in latent hiv at upcoming european society of gene and cell therapy (esgct) 2023 annual congress

SAN FRANCISCO, Oct. 19, 2023 (GLOBE NEWSWIRE) — Excision BioTherapeutics, Inc., a clinical-stage biotechnology company developing CRISPR-based thera...

October 19, 2023, 11:50 am

Maia biotechnology to present preliminary safety and efficacy data from thio-101 phase 2 clinical trial at european society for medical oncology congress 2023

CHICAGO--(BUSINESS WIRE)--MAIA Biotechnology to Present Preliminary Safety and Efficacy Data from THIO-101 ...

October 19, 2023, 8:35 am

Eia weekly us oil inventories -4491k vs -300k expected

Prior was +10176KGasoline -2371K vs -1097K expectedDistillates -3185K vs -1360K expectedRefinery utilization +0.4% vs -% expectedImplied mogas demand ...

October 18, 2023, 2:30 pm

Novo nordisk (nvo) stock falls amid market uptick: what investors need to know

Novo Nordisk (NVO) closed at $101.15 in the latest trading session, marking a -0.97% move from the prior day....

October 16, 2023, 7:33 pm

Omega therapeutics presents new preclinical data supporting the potential of otx-2101 in combination settings for treatment of nsclc

Combination of a MYC-targeting epigenomic controller with immune checkpoint or EGFR inhibitor enhanced anti-tumor activity in models of NSCLC CAMBRIDG...

October 16, 2023, 11:00 am

Relmada and rel-1017: intriguing underlying efficacy in mdd ahead of eventful 2024

Phase 3 trial failures were due to abnormally high placebo responses driven by poor trial design, enrollment, and oversight. REL-1017's underlying eff...

October 13, 2023, 7:50 pm

Bank of canada governor tiff macklem is speaking friday

At 1415 GMT, 1015 US Eastern time: Bank of Canada Governor Tiff Macklem will speak to reporters from the sidelines of the IMF meeting in Marrakech, Mo...

October 13, 2023, 2:36 am

Forexlive americas fx news wrap: yields and dollar spike after terrible bond auction

US September CPI +3.7% y/y versus +3.6% y/y expectedUS initial jobs claims 209K versus 210K estimateUgly Treasury auction sends the dollar even higher...

October 12, 2023, 9:00 pm

Tru precious metals files updated technical report with sedar, and commences fall exploration programme

TRU Precious Metals Corp has filed an updated National Instrument 43-101 technical report for its Golde...

October 11, 2023, 9:30 am

Electric metals closes final tranche of quail bend financing; raises c$5m in total

Electric Metals (TSX-V:EML) (USA) Limited said it has closed the second and final tranche of its previously announced non-brokered financing with Quai...

October 10, 2023, 2:59 pm

Okyo pharma files ind application ok-101 to treat neuropathic corneal pain

OKYO Pharma Ltd (NASDAQ:OKYO), the clinical-stage drug developer noted, told investors it has filed an Investigational New Drug (IND) application wit...

October 9, 2023, 8:20 am

Okyo pharma phase ii dry eye trial making encouraging progress

OKYO Pharma Ltd (NASDAQ:OKYO), the clinical-stage drug developer, has reported encouraging safety data for its ongoing phase II clinical trial of OK-1...

October 5, 2023, 7:58 am

Omega therapeutics to present new preclinical data on otx-2101 at the 2023 aacr-nci-eortc international conference on molecular targets and cancer therapeutics

CAMBRIDGE, Mass., Oct. 04, 2023 (GLOBE NEWSWIRE) -- Omega Therapeutics, Inc. (Nasdaq: OMGA) (“Omega”), a clinical-stage biotechnology company pion...

October 4, 2023, 4:00 pm

Gbp/usd price gains above 1.21 as dollar takes breather

Taking out the 1.2101 signaled more gains. The downtrend line stands as a potential target. The US econ...

October 4, 2023, 11:23 am

Nrx pharma (nrxp) to initiate clinical study on nrx-101, stock up

NRx Pharma (NRXP) receives FDA clearance to begin clinical development for its lead candidate, NRX-101, to treat chronic pain....

October 3, 2023, 10:31 am

J.c. flowers-backed vericity to be acquired for 101% premium to monday's close

Vericity Inc.'s VERY, -3.39% stock was up by 97% after the Des Plaines, Ill.-based insurance services company backed by private-equity firm J.C....

October 3, 2023, 8:05 am


Search within

Pages Search Results: